Total Payments
$41,202
2024 Payments
$1,680
Companies
43
Transactions
475
Medicare Patients
7,280
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$27,978 (67.9%)
Food & Beverage$10,299 (25.0%)
Travel$1,270 (3.1%)
Consulting$1,224 (3.0%)
Education$431.93 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,250 | 25 | 63.7% |
| Food and Beverage | $10,299 | 417 | 25.0% |
| Honoraria | $1,328 | 1 | 3.2% |
| Travel and Lodging | $1,270 | 7 | 3.1% |
| Consulting Fee | $1,224 | 1 | 3.0% |
| Education | $431.93 | 23 | 1.0% |
| Grant | $400.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $32,031 | 113 | $0 (2024) |
| Horizon Therapeutics plc | $1,969 | 29 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $849.91 | 39 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $658.95 | 15 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $503.80 | 20 | $0 (2024) |
| Relypsa, Inc. | $500.74 | 27 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $427.77 | 31 | $0 (2024) |
| Vifor Pharma, Inc. | $328.91 | 14 | $0 (2024) |
| Daiichi Sankyo Inc. | $303.74 | 15 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $279.15 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,680 | 70 | AstraZeneca Pharmaceuticals LP ($461.88) |
| 2023 | $3,952 | 58 | AstraZeneca Pharmaceuticals LP ($2,711) |
| 2022 | $12,145 | 57 | AstraZeneca Pharmaceuticals LP ($11,470) |
| 2021 | $3,869 | 79 | AstraZeneca Pharmaceuticals LP ($2,800) |
| 2020 | $11,054 | 61 | AstraZeneca Pharmaceuticals LP ($8,953) |
| 2019 | $6,687 | 68 | AstraZeneca Pharmaceuticals LP ($5,623) |
| 2018 | $934.87 | 49 | Keryx Biopharmaceuticals, Inc. ($158.03) |
| 2017 | $880.92 | 33 | Mallinckrodt LLC ($446.13) |
All Payment Transactions
475 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Hyperkalemia | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Rare Disease | ||||||
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 12/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEPHROLOGY | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.78 | General |
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: NEPHROLOGY | ||||||
| 10/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/25/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $83.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Cardio-renal | ||||||
| 09/04/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 2,400 | 13,410 | $974,371 | $307,188 |
| 2022 | 33 | 1,913 | 11,196 | $902,905 | $276,903 |
| 2021 | 21 | 1,542 | 3,902 | $961,063 | $317,015 |
| 2020 | 22 | 1,425 | 3,544 | $772,360 | $281,694 |
Total Patients
7,280
Total Services
32,052
Medicare Billing
$1.2M
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 282 | 1,541 | $325,459 | $111,135 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 204 | 251 | $101,120 | $29,947 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 347 | $134,508 | $29,154 | 21.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 214 | $64,836 | $23,209 | 35.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 19 | 71 | $75,127 | $23,201 | 30.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 23 | 79 | $69,113 | $21,507 | 31.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 54 | 219 | $27,156 | $11,722 | 43.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 26 | 195 | $29,543 | $8,775 | 29.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 89 | 173 | $19,388 | $7,949 | 41.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 34 | $28,853 | $6,672 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $15,273 | $4,486 | 29.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 66 | 83 | $8,566 | $3,357 | 39.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 74 | 86 | $6,364 | $2,495 | 39.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $8,834 | $2,370 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 33 | $9,001 | $2,312 | 25.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 138 | 252 | $2,429 | $2,022 | 83.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $6,527 | $1,785 | 27.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 20 | $6,111 | $1,542 | 25.2% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 14 | 8,400 | $4,620 | $1,388 | 30.0% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 13 | 39 | $4,985 | $1,387 | 27.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $2,135 | $1,056 | 49.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 93 | 127 | $2,685 | $1,053 | 39.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 58 | 76 | $2,589 | $1,015 | 39.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 121 | 170 | $2,202 | $859.99 | 39.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 72 | 107 | $2,078 | $814.27 | 39.2% |
About Dr. Sayed Ali, M.D
Dr. Sayed Ali, M.D is a Nephrology healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194721191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sayed Ali, M.D has received a total of $41,202 in payments from pharmaceutical and medical device companies, with $1,680 received in 2024. These payments were reported across 475 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($26,250).
As a Medicare-enrolled provider, Ali has provided services to 7,280 Medicare beneficiaries, totaling 32,052 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Manhasset, NY
- Active Since 06/23/2005
- Last Updated 03/22/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1194721191
Products in Payments
- LOKELMA (Drug) $29,359
- FARXIGA (Drug) $2,294
- KRYSTEXXA (Biological) $1,986
- ACTHAR (Biological) $1,163
- Veltassa (Drug) $829.65
- JYNARQUE (Drug) $723.63
- RAYALDEE (Drug) $343.03
- PURIFIED CORTROPHIN GEL (Drug) $305.39
- INJECTAFER (Drug) $303.74
- Auryxia (Drug) $284.86
- Velphoro (Drug) $279.15
- XARELTO (Drug) $274.67
- Kerendia (Drug) $244.72
- ULTOMIRIS (Biological) $237.25
- GATTEX (Drug) $203.70
- Varithena Administration Pack (Device) $163.64
- AURYXIA (Drug) $144.65
- JARDIANCE (Drug) $131.11
- SAMSCA (Drug) $126.28
- LUPKYNIS (Drug) $110.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Manhasset
Gerard Tepedino
Nephrology — Payments: $325,865
Nephrology $325,865
Dr. Jeffrey Cohen, M.d, M.D
Nephrology — Payments: $68,784
Nephrology $68,784
Dr. Simon Prince, D.o, D.O
Nephrology — Payments: $12,859
Nephrology $12,859
Aarti Bhasin, Md, Mph, MD, MPH
Nephrology — Payments: $5,560
Nephrology $5,560
Ronald Villareal, Md, MD
Nephrology — Payments: $1,459
Nephrology $1,459
Vinay Nair, D.o, D.O
Nephrology — Payments: $864.50
Nephrology $864.50